Literature DB >> 7704922

Public health control of hepatitis A: memorandum from a WHO meeting.

.   

Abstract

Hepatitis A virus infection is a significant cause of morbidity in many parts of the world, and hepatitis A vaccines will be important tools for its prevention and control. This Memorandum reviews the basic features of the disease and its epidemiology, and considers the measures which are available for control and prevention, including hepatitis A vaccine. The use of this vaccine should be adapted to specific epidemiological circumstances existing within a geographical region, with special attention to the cost-effectiveness of immunization programmes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7704922      PMCID: PMC2486586     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  11 in total

1.  Cost effectiveness of alternative hepatitis A immunisation strategies.

Authors:  E van Doorslaer; G Tormans; P van Damme; P Beutels
Journal:  Pharmacoeconomics       Date:  1995-07       Impact factor: 4.981

2.  The Seroconversion Rate of Hepatitis A Virus Vaccination among Patients with Hepatitis B Virus-Related Chronic Liver Disease in Korea.

Authors:  Hyun Chin Cho; Yu Jin Kim; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Byung Chul Yoo; Seung Woon Paik
Journal:  Gut Liver       Date:  2011-06-23       Impact factor: 4.519

3.  Hepatitis A in urban Ireland.

Authors:  E Rajan; B O'Farrell; A G Shattock; J F Fielding
Journal:  Ir J Med Sci       Date:  1998 Oct-Dec       Impact factor: 1.568

4.  Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy.

Authors:  M E Moschen; A Floreani; E Zamparo; V Baldo; S Majori; V Gasparini; R Trivello
Journal:  Eur J Epidemiol       Date:  1997-12       Impact factor: 8.082

5.  Prevalence of hepatitis A antibodies in food handlers in Italy.

Authors:  I F Angelillo; C G Nobile; F Talarico; M Pavia
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

6.  Cost of an outbreak of hepatitis A in Puglia, Italy.

Authors:  C Lucioni; V Cipriani; S Mazzi; M Panunzio
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

7.  Vaccination rate and seroepidemiology of hepatitis a in chronic-hepatitis-B-infected individuals in the korean army.

Authors:  Dong Hyuk Shin; Sang Kuk Han; Pil Cho Choi; Seong Woo Lim; Kyung Mook Kim; Dong Hyun Sinn
Journal:  Gut Liver       Date:  2010-06-16       Impact factor: 4.519

8.  Foodborne spread of hepatitis A: Recent studies on virus survival, transfer and inactivation.

Authors:  S A Sattar; T Jason; S Bidawid; J Farber
Journal:  Can J Infect Dis       Date:  2000-05

9.  A retrospective pooled analysis assessing the effect of age on the immunogenicity of Havrix™ in healthy adults.

Authors:  Olivier Van Der Meeren; Priya Crasta; Marc de Ridder
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

10.  Vaccination against hepatitis A in children: A review of the evidence.

Authors:  Paolo Bonanni; Sara Boccalini; Angela Bechini
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.